Syngene International Ltd. reported consolidated revenue from operations of ₹9.17 billion for the December quarter, alongside a net profit of ₹150 million. The results reflect steady growth in contract research and manufacturing services, though profitability remains modest amid rising costs and sectoral challenges in India’s biopharma outsourcing industry.
Show moreStay Ahead – Explore Now! Shanthi Gears Declares Interim Dividend, CFO Steps Down
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
